The investigators are collecting genetic information through blood samples as well as clinical and EEG data from over 1000 people with Juvenile Myoclonic Epilepsy (JME) across the UK, Europe and North America. This study will draw on both existing and new samples from JME patients. These will be compared to anonymised data from samples for 2000 controls. The goal of this study is to find the genetic cause of JME. Finding the cause will help create better treatments for JME, as well as improve patient outcomes by allowing us to detect it earlier.
Juvenile Myoclonic Epilepsy
The investigators are collecting genetic information through blood samples as well as clinical and EEG data from over 1000 people with Juvenile Myoclonic Epilepsy (JME) across the UK, Europe and North America. This study will draw on both existing and new samples from JME patients. These will be compared to anonymised data from samples for 2000 controls. The goal of this study is to find the genetic cause of JME. Finding the cause will help create better treatments for JME, as well as improve patient outcomes by allowing us to detect it earlier.
Biology of Juvenile Myoclonic Epilepsy
-
Mount Sinai-Beth Israel Medical Center, New York, New York, United States, 10003
St Luke's Roosevelt Hospital, New York, New York, United States, 10025
Nationwide Children's Hospital, Columbus, Ohio, United States, 43125
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
10 Years to 40 Years
ALL
No
King's College London,
K Pal, MD PhD, PRINCIPAL_INVESTIGATOR, King's College London
2026-06-30